Cargando…

Maintenance Pharmacotherapies for Neuropsychiatric Disorders

Detalles Bibliográficos
Autor principal:	Richards, Stephanie
Lenguaje:	eng
Publicado:	Routledge 2013
Materias:	XX
Acceso en línea:	http://cds.cern.ch/record/2726489

Ejemplares similares

Neuropsychiatric Symptoms in Dementia: Considerations for Pharmacotherapy in the USA
por: Phan, Stephanie V., et al.
Publicado: (2019)

Pharmacotherapy of Schizophrenia in Acute and Maintenance Phase
por: KIRLI, Umut, et al.
Publicado: (2021)

Bayesian regularization to predict neuropsychiatric adverse events in smoking cessation with pharmacotherapy
por: Truong, Van Thi Thanh, et al.
Publicado: (2023)

Maintenance electroconvulsive therapy for comorbid pharmacotherapy-refractory obsessive-compulsive and schizoaffective disorder
por: Hanisch, F, et al.
Publicado: (2009)

Efficacy of Antidopaminergic Pharmacotherapy in Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections (PANDAS): A Case Report
por: Hefelfinger, Donald, et al.
Publicado: (2023)

Herb-drug Interactions in Neuropsychiatric Pharmacotherapy – A Review of Clinically Relevant Findings
por: Le, Tram T., et al.
Publicado: (2022)

Pharmacotherapy of panic disorder
por: Pull, Charles B, et al.
Publicado: (2008)

The Effectiveness of Maintenance Pharmacotherapies for Non-Small Cell Lung Cancer
por: Ahn, Myung-Ju, et al.
Publicado: (2012)

Pharmacotherapy for acid/peptic disorders.
por: Schubert, M. L.
Publicado: (1996)

Challenges in the Pharmacotherapy of Urogenital Disorders
por: Michel, Martin C.
Publicado: (2010)

Update on Pharmacotherapy in Psychodermatological Disorders
por: Shenoi, Shrutakirthi D., et al.
Publicado: (2020)

Pharmacotherapy in patients with vasomotor disorders
por: Boerhout, C.K.M., et al.
Publicado: (2023)

Reelin and Neuropsychiatric Disorders
por: Ishii, Kazuhiro, et al.
Publicado: (2016)

Autoantibodies in Neuropsychiatric Disorders
por: Hoffmann, Carolin, et al.
Publicado: (2016)

The genetics of neuropsychiatric disorders
por: Bray, Nicholas J., et al.
Publicado: (2018)

Pharmacotherapy for anxiety disorders in children and adolescents
por: Kodish, Ian, et al.
Publicado: (2011)

Pharmacotherapy for Insomnia Disorder in Older Adults
por: Grandner, Michael A., et al.
Publicado: (2019)

Pharmacotherapy treatment of stimulant use disorder
por: Liu, Mei T.
Publicado: (2021)

Long‐term weight loss maintenance with obesity pharmacotherapy: A retrospective cohort study
por: Tchang, Beverly G., et al.
Publicado: (2021)

Relevant Issues in Pharmacotherapy of Psycho-Cutaneous Disorders
por: Ghosh, Sreyoshi, et al.
Publicado: (2013)

Pharmacotherapy of anxiety disorders: a critical review
por: Koen, Nastassja, et al.
Publicado: (2011)

Evaluation of pharmacotherapy in inpatients with mania in bipolar disorder
por: Piróg-Balcerzak, Agnieszka, et al.
Publicado: (2010)

Update on the pharmacotherapy of cerebellar and central vestibular disorders
por: Kalla, Roger, et al.
Publicado: (2016)

Practical outpatient pharmacotherapy for alcohol use disorder
por: Kim, Youngjung, et al.
Publicado: (2018)

Mechanisms and Pharmacotherapy for Ethanol-Responsive Movement Disorders
por: Wu, Jingying, et al.
Publicado: (2020)

Treatment of posttraumatic stress disorder: Focus on pharmacotherapy
por: Ehret, Megan
Publicado: (2019)

Editorial: Pharmacotherapy of Anxiety Disorders: Promises and Pitfalls
por: Garakani, Amir, et al.
Publicado: (2021)

Pharmacotherapy for borderline personality disorder: A review
por: Lietor, M.D.C. Molina, et al.
Publicado: (2021)

Cost-effectiveness of psychotherapies and pharmacotherapies for mental disorders
por: McCrone, P.
Publicado: (2023)

The possible place for psychedelics in pharmacotherapy of mental disorders
por: Wojtas, Adam
Publicado: (2023)

Fatty acids and neuropsychiatric disorders
por: Puri, Basant K
Publicado: (2008)

Neuropsychiatric disorders in Cushing's syndrome
por: Pivonello, Rosario, et al.
Publicado: (2015)

Epigenetic Regulations in Neuropsychiatric Disorders
por: Kuehner, Janise N., et al.
Publicado: (2019)

Neuropsychiatric disorders and COVID-19
por: Charlton, Elizabeth, et al.
Publicado: (2021)

Neuropsychiatric disorders and COVID-19
por: Finsterer, Josef
Publicado: (2021)

Neuropsychiatric disorders and COVID-19
por: Burchill, Ella, et al.
Publicado: (2021)

The Histaminergic System in Neuropsychiatric Disorders
por: Cheng, Li, et al.
Publicado: (2021)

Gut Bacteria and Neuropsychiatric Disorders
por: Dicks, Leon M. T., et al.
Publicado: (2021)

Gut microbiome in neuropsychiatric disorders
por: MEJÍA-GRANADOS, Diana Marcela, et al.
Publicado: (2022)

Gut Microbiota and Neuropsychiatric Disorders
por: Bidaki, Reza, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l2fkrpm3jtv5jce0n8umvo3a0c